See the Complete Picture.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Aviation Accidents
Riots
Artificial Intelligence
Donald Trump
Immigration
Immigration and Customs Enforcement
Social Media
US Immigration
World Cup
Soccer
Bola Tinubu
US Politics
Published • loading... • Updated

Hesperos, Psilera Agree to Accelerate Organ-on-a-Chip Treatment for Frontotemporal Dementia

Summary by pharmtech.com
The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound targeting the progressive neurological disorder for which treatment options are few.

1 Articles

All
Left
Center
1
Right
pharmtech.compharmtech.com
Center

Hesperos, Psilera Agree to Accelerate Organ-on-a-Chip Treatment for Frontotemporal Dementia

The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound targeting the progressive neurological disorder for which treatment options are few.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

pharmtech.com broke the news in on Monday, June 9, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
For You
SearchBlindspotLocal